Main > A1. CORP. INDEX. Cn-Cz > CSL Ltd./P C2 > CSL Behring/P C2
CSL Behring/P C2's subsections
2007. 07.10. Blood Coag.
2007. 12.19. Iran >
2008. 03.17. Immuno.>P
2012. 02.24. Hemophilia A
2012. 03.15. Cardio.>Aortic
2012. 03.26. Neuro.>CIDP
2012. 03.30. Hemophilia
2012. 06.27. Neuro.>CIDP
2013. 02.28. Blood Coag.
2013. 04.16. Genetic Dis.>HAE
2013. 12.05. Immuno.>H
2013. 12.13. Warfarin Reversal
2016. 03.04. Hemophilia B
2017. 06.23. Genetic Dis.>HAE
2017. 09.14. Neuro.>CIDP USA>OK
2019. 03.26. Neuro.>CIDP JP>OK
2019. 04.25. Alpha 1 USA Approval
2020. 04.08. COVID-19 Therapeutic
2020. 06.08. Acq. Vitaeris
2020. 06.24. Acq. UniQure
2020. 09.28. Genetic Dis.>HAE
Centeon/P
Web-Site
Z - OK
CSL Behring/P C2's products
This section has no products